A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MMM

Search Conditions:
Search Keyword : MMM
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: MMM
Appearance Frequency: 662 time(s)
Long forms: 162

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
myelofibrosis with myeloid metaplasia
(155 times)
Hematology
(107 times)
PV (29 times)
ET (24 times)
CML (11 times)
1975 [Subacute myelogenous leukemia with Phildelphia chromosome].
May Measurement Month
(98 times)
Vascular Diseases
(3 times)
BP (93 times)
ISH (9 times)
HTN (8 times)
2017 May Measurement Month: a new joint global initiative by the International Society of Hypertension and the World Hypertension League to raise awareness of raised blood pressure.
mixed matrix membrane
(62 times)
Chemistry
(16 times)
MOF (7 times)
MOFs (6 times)
PVDF (5 times)
2011 Mixed matrix membrane incorporated with large pore size halloysite nanotubes (HNT) as filler for gas separation: experimental.
metastatic malignant melanoma
(19 times)
Neoplasms
(11 times)
PMM (2 times)
ADC (1 time)
AI (1 time)
1990 A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma.
Multifocal multiphoton microscopy
(17 times)
Ophthalmology
(8 times)
MAPMT (3 times)
SLM (3 times)
SNR (3 times)
2000 Live cell imaging by multifocal multiphoton microscopy.
mucosal malignant melanoma
(15 times)
Neoplasms
(6 times)
RR (2 times)
RT (2 times)
ALES (1 time)
1999 Primitive sinonasal malignant mucosal melanoma: description of a case treated with radiotherapy (0-7-21 regimen).
multimodality monitoring
(15 times)
Neurology
(7 times)
ICP (4 times)
SBI (4 times)
CBF (3 times)
2013 Multimodality monitoring in the neurointensive care unit: a special perspective for patients with stroke.
medium-mass molecules
(13 times)
Medicine
(2 times)
MDA (3 times)
AA (1 time)
AOA (1 time)
1989 [Middle molecules as an indicator of the degree of disruption of blood coagulation in hemophilia].
magnetic marker monitoring
(11 times)
Pharmacology
(7 times)
GI (5 times)
ER (2 times)
RCC (2 times)
1999 Magnetic marker monitoring of esophageal, gastric and duodenal transit of non-disintegrating capsules.
10  metal-molecule-metal
(11 times)
Chemistry
(5 times)
SAMs (3 times)
CP-AFM (2 times)
DFT (2 times)
2006 Correlation between HOMO alignment and contact resistance in molecular junctions: aromatic thiols versus aromatic isocyanides.
11  myeloid metaplasia with myelofibrosis
(11 times)
Hematology
(5 times)
PV (4 times)
ET (3 times)
HT (2 times)
1977 Ph1-positive polycythemia vera.
12  marginal metallophilic macrophages
(8 times)
Microbiology
(2 times)
MZM (5 times)
MZ (4 times)
DCs (2 times)
1995 Brucella abortus causes an accelerated repopulation of the spleen and liver of mice by macrophages after their liposome-mediated depletion.
13  Modified Monash Model
(8 times)
Public Health
(4 times)
AHPRA (2 times)
ASGC-RA (2 times)
SEIFA (2 times)
2016 The changing landscape of physiotherapy student clinical placements: An exploration of geographical distribution andstudent performance across settings.
14  Marijuana Motives Measure
(7 times)
Substance-Related Disorders
(7 times)
CFA (2 times)
ARCI (1 time)
CAST (1 time)
2006 Marijuana use motives: concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers.
15  Methadone medical maintenance
(6 times)
Substance-Related Disorders
(4 times)
--- 2000 Methadone medical maintenance (MMM): treating chronic opioid dependence in private medical practice--a summary report (1983-1998).
16  mitozantrone, methotrexate and mitomycin C
(6 times)
Neoplasms
(5 times)
TTP (2 times)
CG (1 time)
CRs (1 time)
1991 A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
17  mixture model method
(6 times)
Medical Informatics
(3 times)
SAM (4 times)
EB (2 times)
FDR (1 time)
2003 Modified nonparametric approaches to detecting differentially expressed genes in replicated microarray experiments.
18  masticatory muscle myositis
(5 times)
Veterinary Medicine
(3 times)
EMG (1 time)
IM (1 time)
IMs (1 time)
1995 Muscle fibre expression of transforming growth factor-beta 1 and latent transforming growth factor-beta binding protein in canine masticatory muscle myositis.
19  maternal morbidity and mortality
(5 times)
Neurosurgical Procedures
(1 time)
CI (1 time)
E-utilities (1 time)
ES (1 time)
2016 Perioperative risk factors impact outcomes in emergency versus nonemergency surgery differently: Time to separate our national risk-adjustment models?
20  malignant mucosal melanoma
(4 times)
Neoplasms
(3 times)
ACC (1 time)
ADC (1 time)
C-ion RT (1 time)
1998 Primary malignant melanoma of the mucous membranes.
21  membrane, magnesium, mitosis
(4 times)
Drug Therapy
(1 time)
--- 2005 Magnesium: The missing element in molecular views of cell proliferation control.
22  metal magnetic memory
(4 times)
Medicine
(1 time)
EMA (1 time)
NPMD (1 time)
RSR (1 time)
2013 High sensitive methods for health monitoring of compressor blades and fatigue detection.
23  maximum monthly mean
(3 times)
Environmental Health
(2 times)
CRS (1 time)
GoA (1 time)
2018 The bioeroding sponge Cliona orientalis will not tolerate future projected ocean warming.
24  Mayo Molecular Model
(3 times)
Hematology
(3 times)
CMML (3 times)
CPSS-Mol (3 times)
GFM (3 times)
2018 Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.
25  mechanical middle ear model
(3 times)
Otolaryngology
(2 times)
CAD (1 time)
CoMEP (1 time)
LDV (1 time)
1998 [Measuring vibration properties of middle ear implants with the mechanical middle ear model. Initial results].
26  Medical Management
(3 times)
Education
(2 times)
ACPE (1 time)
2002 Carnegie Mellon University's MMM program: management education for 21st-century physicians.
27  methylmethacrylate monomer
(3 times)
Orthodontics
(1 time)
--- 1977 Some aspects of pulmonary excretion of methylmethacrylate monomer (MMM) in dogs.
28  multi-male mating
(3 times)
Behavioral Sciences
(1 time)
--- 2002 Multi-male mating, probability of conception, and litter size in the prairie vole (Microtus ochrogaster).
29  Multiple Mapping Method
(3 times)
Biochemistry
(2 times)
MT (1 time)
2006 Multiple mapping method: a novel approach to the sequence-to-structure alignment problem in comparative protein structure modeling.
30  multiple molecular markers
(3 times)
Virology
(2 times)
CTV (3 times)
CC (1 time)
CCPP (1 time)
2005 Assessment of sequence diversity in the 5'-terminal region of Citrus tristeza virus from India.
31  malignant melanoma
(2 times)
Neoplasms
(1 time)
BMN (1 time)
cCD44std (1 time)
cICAM-1 (1 time)
1993 Proliferative activity in Spitz's naevi compared with other melanocytic skin lesions.
32  Malteser Migranten Medizin
(2 times)
Public Health
(1 time)
--- 2015 [Health Status of Persons without Health Insurance and of Undocumented Migrants: Analysis of Data from the Malteser Migranten Medizin (MMM) in Munich, Germany].
33  maternal mortality and morbidity
(2 times)
Women's Health
(1 time)
FSWs (1 time)
MDGs (1 time)
2012 Integrating interventions on maternal mortality and morbidity and HIV: a human rights-based framework and approach.
34  mean molecular mass
(2 times)
Biotechnology
(2 times)
DOT (2 times)
OTR (2 times)
SAPR (1 time)
2007 The oxygen transfer rate influences the molecular mass of the alginate produced by Azotobacter vinelandii.
35  meaning maintenance model
(2 times)
Nervous System
(1 time)
RewP (1 time)
SW (1 time)
2006 The meaning maintenance model: on the coherence of social motivations.
36  metastatic melanoma
(2 times)
Pathology
(2 times)
Arg (1 time)
BM (1 time)
BN (1 time)
1999 PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
37  methotrexate, mitomycin-c and mitoxantrone
(2 times)
Drug Therapy
(1 time)
CT (2 times)
MBC (2 times)
beta-IFN (1 time)
1995 Beta-interferon, retinoids and tamoxifen as maintenance therapy in metastatic breast cancer. A pilot study.
38  microfluidic microvasculature mimetic
(2 times)
Biochemistry
(1 time)
HC (1 time)
LDGs (1 time)
NDNs (1 time)
2016 Chemotherapy impedes invitro microcirculation and promotes migration of leukemic cells with impact on metastasis.
39  mitomycin-C, mitoxantrone, and methotrexate
(2 times)
Neoplasms
(2 times)
--- 1992 Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexate.
40  mixed matrix hollow fiber membranes
(2 times)
Chemistry
(1 time)
AC (1 time)
OIF (1 time)
2017 Treatment of methylene blue containing wastewater by a cost-effective micro-scale biochar/polysulfone mixed matrix hollow fiber membrane: Performance and mechanism studies.
41  model minority myth
(2 times)
Psychology
(1 time)
--- 2021 Internalized model minority myth among Asian Americans: Links to anti-Black attitudes and opposition to affirmative action.
42  multi-marker methods
(2 times)
Neoplasms
(1 time)
BA (1 time)
BL (1 time)
LD (1 time)
2014 Next generation modeling in GWAS: comparing different genetic architectures.
43  multi-model median
(2 times)
Natural Science Disciplines
(1 time)
Bln (1 time)
Gen (1 time)
GHG (1 time)
2020 The effects of anthropogenic and volcanic aerosols and greenhouse gases on twentieth century Sahel precipitation.
44  multilevel measurement model
(2 times)
Statistics as Topic
(2 times)
CCREM (1 time)
HGLM (1 time)
2005 The multilevel measurement model: introduction to the special issue.
45  multiphoton microfabrication and micropatterning
(2 times)
Biomedical Engineering
(1 time)
bBMP-2 (1 time)
BMP-2 (1 time)
NA (1 time)
2021 Multiphoton microfabrication and micropatterning (MMM) - An all-in-one platform for engineering biomimetic soluble cell niches.
46  multiple male mating
(2 times)
Ecology
(1 time)
FPS (1 time)
LS (1 time)
MP (1 time)
2010 The heritability of multiple male mating in a promiscuous mammal.
47  M. maximus-monoculture
(1 time)
CI (1 time)
CP (1 time)
SPS (1 time)
2020 Increase in Milk Yield from Cows through Improvement of Forage Production Using the N2-Fixing Legume Leucaena leucocephala in a Silvopastoral System.
48  Magnetic Micro-Machines
(1 time)
Biomedical Engineering
(1 time)
--- 2009 Fabrication of new Magnetic Micro-Machines for minimally invasive surgery.
49  major maternal morbidity
(1 time)
Hypertension, Pregnancy-Induced
(1 time)
SPRE (1 time)
2012 PP039. The importance of intentionally considering class 1 HELLP syndrome outcomes versus all other categories of HELLP syndrome or severe preeclampsia.
50  Making More of Math
(1 time)
Behavioral Sciences
(1 time)
EF (1 time)
2017 The DREME Network: Research and Interventions in Early Childhood Mathematics.
51  male-male mounting
(1 time)
Natural Science Disciplines
(1 time)
--- 2017 Increased Male-Male Mounting Behaviour in Desert Locusts during Infection with an Entomopathogenic Fungus.
52  Malignant melanoma with myxoid features
(1 time)
Cell Biology
(1 time)
FNA (1 time)
2019 Fine needle aspiration of malignant melanoma with myxoid features: A case report with molecular analysis.
53  malignant mixed mesodermal
(1 time)
Gynecology
(1 time)
LMS (1 time)
1984 Uterine sarcomas: a clinicopathologic study, 1965-1981.
54  Malignant myxoid melanoma
(1 time)
Dermatology
(1 time)
--- 2002 Myxoid melanoma: immunohistochemical studies and a review of the literature.
55  mammillary bodies
(1 time)
Brain
(1 time)
FR (1 time)
IPN (1 time)
LHRH (1 time)
1983 Effects of lesions of putative LHRH-containing pathways and midbrain nuclei on lordotic behavior and luteinizing hormone release in ovariectomized rats.
56  Man Material Medium
(1 time)
Toxicology
(1 time)
COVID-19 (1 time)
GLP (1 time)
2021 Managing COVID-19 Lockdown Impacts: Sustaining GLP Compliance and Man Material Medium (MMM) Strategy for Augmenting Prevention of Workplace Infections.
57  Man, Material, and Medium
(1 time)
Toxicology
(1 time)
COVID-19 (1 time)
GLP (1 time)
2021 Managing COVID-19 Lockdown Impacts: Sustaining GLP Compliance and Man Material Medium (MMM) Strategy for Augmenting Prevention of Workplace Infections.
58  man-made mineral fibers
(1 time)
Environmental Health
(1 time)
--- 1983 Macrophage functions after exposure to mineral fibers.
59  manual micromanipulator
(1 time)
Otolaryngology
(1 time)
P/A (1 time)
RMC (1 time)
2015 The application of robotics to microlaryngeal laser surgery.
60  manual morcellation through mini-laparotomy
(1 time)
Gynecology
(1 time)
MMV (1 time)
PM (1 time)
2015 Comparison of methods of morcellation: manual versus power.
61  manualized Matrix Model
(1 time)
Substance-Related Disorders
(1 time)
OTP (1 time)
2011 Comparison of buprenorphine treatment for opioid dependence in 3 settings.
62  many-to-many image superpixel matching
(1 time)
Cybernetics
(1 time)
--- 2014 Many-to-many superpixel matching for robust tracking.
63  Mapping, Measuring, Monitoring
(1 time)
Medicine
(1 time)
MRV (1 time)
2016 Moving from Measuring, Reporting, Verification (MRV) of Forest Carbon to Community Mapping, Measuring, Monitoring (MMM): Perspectives from Mexico.
64  Marginalized Multilevel Models
(1 time)
Pharmacology
(1 time)
GLMM (1 time)
2019 Marginalized models for right-truncated and interval-censored time-to-event data.
65  marine minimal medium
(1 time)
Environmental Health
(1 time)
Glt (1 time)
2009 Nitrogen regulates chitinase gene expression in a marine bacterium.
66  marker motion magnitude
(1 time)
Radiology
(1 time)
AP (1 time)
eNAL (1 time)
LR (1 time)
2017 Assessment with cone-beam computed tomography of intrafractional motion and interfractional position changes of resectable and borderline resectable pancreatic tumours with implanted fiducial marker.
67  Markov model mediator
(1 time)
Biomedical Engineering
(1 time)
--- 2004 Stochastic clustering for organizing distributed information sources.
68  mass-minus-many
(1 time)
Molecular Biology
(1 time)
--- 2019 Visualization of Mass Cytometry Signal Background to Enable Optimal Core Panel Customization and Signal Threshold Gating.
69  material mapping method
(1 time)
Biomedical Engineering
(1 time)
FE (1 time)
SWF (1 time)
2016 The influence of the modulus-density relationship and the material mapping method on the simulated mechanical response of the proximal femur in side-ways fall loading configuration.
70  May Month Measurement
(1 time)
BP (1 time)
2021 May Measurement Month 2019: an analysis of blood pressure screening results from Brazil.
71  McMaster Molecular Media
(1 time)
Virology
(1 time)
POCT (1 time)
rRT-PCR (1 time)
2021 One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™.
72  MCP-1, Mip-1alpha, and Mip-2alpha
(1 time)
Immune System Diseases
(1 time)
MK2 (1 time)
2018 MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth.
73  Mean Motion Model
(1 time)
Biomedical Engineering
(1 time)
AVC (1 time)
PCA (1 time)
SMFP (1 time)
2017 Patient-specific respiratory motion estimation using Sparse Motion Field Presentation.
74  Medical Module Manager
(1 time)
Military Medicine
(1 time)
R2A (1 time)
2017 The Role 2 Afloat custodian.
75  Medications and Mother's Milk
(1 time)
Nutritional Sciences
(1 time)
--- 2009 The identifying and counseling of breastfeeding women by pharmacists.
76  medium maturing middle
(1 time)
Botany
(1 time)
EML (1 time)
HD (1 time)
LMM (1 time)
2009 The distribution of japonica rice cultivars in the lower region of the Yangtze River valley is determined by its photoperiod-sensitivity and heading date genotypes.
77  medium-molar mass
(1 time)
Microbiology
(1 time)
DOC (1 time)
2006 Bacterial growth and community composition in fractions of dissolved organic carbon of different molar mass from interstitial water.
78  MERRA-2 MODIS merged
(1 time)
Environmental Health
(1 time)
AERONET (1 time)
AOD (1 time)
2020 Long-term aerosol optical depth trend over Iran and identification of dominant aerosol types.
79  meta-metamaterial
(1 time)
Biophysics
(1 time)
--- 2018 Casimir repulsion in superparamagnetic metamaterial constructed by non-monodisperse nanoparticles.
80  metabolites--middle mass molecules
(1 time)
General Surgery
(1 time)
CIC (1 time)
1990 [Evaluation of the degree of ischemia of the lower extremities in arteriosclerosis obliterans based on the levels of toxic metabolites in the blood].
81  metastatic meningeal melanomatosis
(1 time)
Neoplasms
(1 time)
CSF (1 time)
SCM (1 time)
1993 Intrathecal IgM response in disseminated cerebrospinal metastasis from malignant melanoma.
82  methotrexate, mitozantrone and mitomycin C
(1 time)
Neoplasms
(1 time)
ER (1 time)
2001 Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy.
83  MF with myeloid metaplasia
(1 time)
Pathology
(1 time)
BM (1 time)
MF (1 time)
2007 Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
84  Michaelis-Menten-Monod
(1 time)
Environmental Health
(1 time)
AMPA (1 time)
GLP (1 time)
2017 Analysis of glyphosate degradation in a soil microcosm.
85  microfluidic membrane mimic
(1 time)
Natural Science Disciplines
(1 time)
--- 2019 Investigating fouling at the pore-scale using a microfluidic membrane mimic filtration system.
86  Military Medical Museum
(1 time)
Otolaryngology
(1 time)
--- 2012 [The magnitude and the structure of ENT sanitary losses in modern local armed conflicts].
87  mimicking myelofibrosis with myelocytic metaplasia
(1 time)
Genetics, Medical
(1 time)
PPMF (1 time)
PV (1 time)
2003 Karyotypic abnormalities in myelofibrosis following polycythemia vera.
88  Mind My Mind
(1 time)
Mental Disorders
(1 time)
CBT (1 time)
MAU (1 time)
SDQ (1 time)
2020 Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems: A Randomized Clinical Trial.
89  Ming-Men mixture
(1 time)
Complementary Therapies
(1 time)
CORT (1 time)
CRF (1 time)
HPAT (1 time)
1995 [Effect of ming-men mixture on corticosterone-rats' neuro-endocrino-immunological network].
90  mini-mindfulness meditation
(1 time)
Medicine
(1 time)
MBST (1 time)
2017 Mindfulness: A New Paradigm of Psychosocial Care in the Palliative Care Setting in Southeast Asia.
91  miniature manipulator with a microelectrode
(1 time)
Neurology
(1 time)
--- 1991 Miniature manipulator with microelectrode for chronic recording of single units from freely-moving animals.
92  minicore-multicore myopathy
(1 time)
Neurology
(1 time)
--- 1991 The natural history of minicore-multicore myopathy.
93  Minimally Mechanized Mining
(1 time)
Environmental Health
(1 time)
HMM (1 time)
2021 Mercury in soils impacted by alluvial gold mining in the Peruvian Amazon.
94  minimum, maximum, and mean
(1 time)
Biosensing Techniques
(1 time)
E-Noses (1 time)
GRNN (1 time)
k-NN (1 time)
2017 A False Alarm Reduction Method for a Gas Sensor Based Electronic Nose.
95  Minimum-Mechanics Model
(1 time)
Physical Fitness
(1 time)
--- 2020 Accuracy of Metabolic Cost Predictive Equations During Military Load Carriage.
96  Mitomycin C, melphalan, and methotrexate
(1 time)
Antineoplastic Agents
(1 time)
--- 1984 Mitomycin C, melphalan and methotrexate combination chemotherapy for palliation of disseminated breast cancer.
97  mitomycin-C and methotrexate
(1 time)
Neoplasms
(1 time)
--- 1991 A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
98  mitomycin-methotrexate-mitoxantrone
(1 time)
Antineoplastic Agents
(1 time)
CMF (1 time)
1996 Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy.
99  mitoxantrone, mitomycin-c and methotrexate
(1 time)
Medicine
(1 time)
LABC (1 time)
LRRT (1 time)
MRM (1 time)
2001 Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
100  mixed malignant mesothelioma
(1 time)
Cell Biology
(1 time)
EMM (1 time)
FNAB (1 time)
LSM (1 time)
1999 Cytopathology of malignant mesothelioma of the pleura in fine-needle aspiration biopsy.